Masitinib as a neuroprotective agent: a scoping review of preclinical and clinical evidence.
Abdullah Ashraf HamadBasma Ehab AmerYousef HawasManar Alaa MabroukMostafa MeshrefPublished in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2023)
The current evidence suggests a promising therapeutic benefit of masitinib in neurodegenerative diseases. However, further research is necessary to validate and expand upon these findings, particularly regarding the precise mechanisms through which masitinib exerts its therapeutic effects. Future studies should also focus on addressing the safety concerns associated with masitinib use.